OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.7500
+0.0500 (7.14%)
Oct 27, 2026, 3:18 PM AEDT
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 27.53 million as of October 27, 2026. It is the 37,269th most valuable company in the world and the 980th biggest in Australia. Its market cap has decreased by 5.06% in one year.
Market Cap
27.53M
Enterprise Value
21.07M
Revenue
5.09M
Global Rank
Country Rank
#980 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 27.53M, an increase of 277.36%. That is a compound annual growth rate of 6.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 27.53M | 50.22% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 46.35M |
| Compumedics | 45.95M |
| Nova Eye Medical | 42.74M |
| Cleo Diagnostics | 41.82M |
| CleanSpace Holdings | 38.49M |
| Micro-X | 30.85M |
| Control Bionics | 28.78M |
| ImpediMed | 16.48M |